-
Patient-derived neuroblastoma model system OHC-NB1
Study
EGAS00001003031
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell RCC-- CA209-025
Study
EGAS00001004292
-
A Single-Cell Atlas of the Multicellular Ecosystem of Primary and Metastatic Hepatocellular Carcinoma
Study
EGAS00001004468
-
H3.3G34R/V-transformed interneuron progenitors co-opt PDGFRA for gliomagenesis
Study
EGAS00001004301
-
Whole genome sequencing (bam files) of 5 samples of myxofibrosarcoma and 5 matched pairs
Study
EGAS00001005444
-
MM samples for epigenomic translocation of H3K4me3 broad domains following super-enhancer hijacking
Study
EGAS00001005684
-
Persistent STAG2 mutation in recurrent pediatric glioblastoma
Study
EGAS00001004340
-
Cell-free DNA fragmentation patterns and personalized sequencing reveal circulating tumor DNA in urine and plasma of glioma patients
Study
EGAS00001004355
-
IMCISION DNAseq
Study
EGAS00001005466
-
Germline elongator mutations in sonic hedgehog medulloblastoma
Study
EGAS00001004126
-
Cancer immune control needs senescence induction by Stat1 dependent cell cycle regulator pathways in tumours
Study
EGAS00001004151
-
A Multifactorial Tumor and Immune Cell Profile Determines Response to Immune Checkpoint blockade in Melanoma
Study
EGAS00001004548
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma - RNA-seq
Study
EGAS00001004552
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma
Study
EGAS00001004564
-
Characterization of DLBCL with a PMBL gene expression signature
Study
EGAS00001005057
-
Immune profiling reveals enrichment of distinct immune signatures in high-risk oral potentially malignant disorders
Study
EGAS00001005520
-
'KOREAN' never-smoker female adenocarcinoma RNA-seq
Study
EGAS00001003789
-
Transcriptional changes in GBM through therapy
Study
EGAS00001003790
-
Targeted sequencing data and shallow whole genome sequencing data of Follicular lymphoma.
Study
EGAS00001005755
-
Mutational landscape of eccrine porocarcinoma (sweat gland tumour)
Study
EGAS00001004632
-
The genomic landscape of early stage ovarian high grade serous carcinoma
Study
EGAS00001005567
-
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity through a pathogenic lipid metabolism-mTOR circuit - 10x Genomics scRNAseq
Study
EGAS00001005098
-
Targeted sequencing of Burkitt lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001004649
-
Sequencing of cancer autopsies and ctDNA
Study
EGAS00001005109
-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666
-
RNA-seq on neuroblastoma PDX model COG-N-519 treated with control miR-1283 and test miR-99b-5p mimics
Study
EGAS00001005581
-
Whole genome sequencing of multiple myeloma identifies novel structural and non-coding mutations.
Study
EGAS00001003164
-
Integrative molecular analysis of pediatric Anaplastic large cell lymphoma reveals subtypes with distinct immune suppression signatures.
Study
EGAS00001004189
-
Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
Study
EGAS00001004763
-
Analysis of exonic somatic variants in light-chain amyloidosis (ALA) and ALA concomitant with multiple myeloma
Study
EGAS00001004214
-
Analysis of IDHwt-glioblastoma samples from paired primary and recurrent tumor samples
Study
EGAS00001003184
-
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma (arrays set)
Study
EGAS00001004314
-
Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes
Study
EGAS00001004235
-
Whole-exome sequencing of ovarian clear cell carcinoma in clinical outliers
Study
EGAS00001004248
-
Short and long-read genome sequencing methodologies for somatic variant detection; genomic analysis of a patient with diffuse large B-cell lymphoma
Study
EGAS00001004266
-
Multiplexed quantification of four neuroblastoma DNA targets in a single droplet digital PCR reaction
Study
EGAS00001004275
-
Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing
Study
EGAS00001004289
-
Efficacy of CDK4/6i in preclinical models of malignant pleural mesothelioma
Study
EGAS00001005352
-
The Landscape of Genetic Alterations in Hepatocellular Carcinoma, 88 matched HCC tumour/normal pairs WGS belongs to ICGC LICA-CN project
Study
EGAS00001002218
-
Whole genome and exome sequencing data of invasive micropapillary carcinoma of breast
Study
EGAS00001005902
-
Single-cell RNA sequencing of 6 follicular lymphoma tumors
Study
EGAS00001005257
-
Comprehensive molecular characterization of brainstem glioma
Study
EGAS00001004341
-
Sclerosing epithelioid fibrosarcoma case report
Study
EGAS00001005215
-
Enhanced reduced representation bisulfite sequencing (eRRBS) on 45 multiple myeloma samples and 3 normal plasma cell
Study
EGAS00001004348
-
Control samples, breast cancer clinical samples and matched patient-derived tumour xenografts (PDTXs) to develop and test a computational approach to discriminate human and mouse sequences in PDTXs
Study
EGAS00001002445
-
Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Study
EGAS00001005222
-
Esophageal Adenocarcinoma Organoid Genomics
Study
EGAS00001005224
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Reduced Representation Bisulfite Sequencing (RRBS) in various tissues to discover DNA methylation markers for the diagnosis of breast and ovarian cancer.
Study
EGAS00001002609
-
Sequencing of an adolescent patient with germline RET mutant alveolar rhabdomyosarcoma
Study
EGAS00001004359
-
Gene expression profiling of nasopharyngeal carcinoma
Study
EGAS00001004542
-
Comprehensive Genomic Characterization of Refractory Multiple Myeloma Reveals a Complex Mutational and Structural Landscape Associated with Drug Resistance (H067)
Study
EGAS00001004363
-
Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
Study
EGAS00001004366
-
tFL with a PMBL GE signature
Study
EGAS00001005870
-
Molecular programs of melanoma brain metastases (MBM)
Study
EGAS00001005976
-
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Study
EGAS00001005981
-
Cerebrospinal fluid circulating tumour DNA allows the characterisation and monitoring of medulloblastoma
Study
EGAS00001004651
-
Multiple Myeloma Total Therapy trial patient sequencing
Study
EGAS00001003223
-
Patient-derived tumor organoids for personalized medicine in a rare case of hepatocellular carcinoma with neuroendocrine differentiation.
Study
EGAS00001005887
-
Neuroblastoma and adrenal gland single-cell study
Study
EGAS00001004388
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
Integrative Profiling of T790M Negative EGFR Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
Study
EGAS00001005389
-
RP-1843 Arcagen - Gastrointestinal rare cancers (GI)
Study
EGAS00001006299
-
Pediatric Papillary Thyroid Carcinoma RNA-Seq
Study
EGAS00001005182
-
A mechanistic classification of clinical phenotypes in neuroblastoma
Study
EGAS00001003244
-
Characterizing the immune and genome landscapes for osteosarcoma
Study
EGAS00001003247
-
Single-cell analysis for metastatic gastric adenocarcinoma
Study
EGAS00001004443
-
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Study
EGAS00001004445
-
Genomic characterization of co-existing biliary tract intraepithelial neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer
Study
EGAS00001005402
-
Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma
Study
EGAS00001003251
-
Brain tumor sequencing data
Study
EGAS00001006352
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase
Study
EGAS00001004455
-
Mutational_burden_in_human_hair_follicles
Study
EGAS00001004462
-
Single cell RNA sequencing of normal endometrial derived organoids uncovers novel cell type markers for prognostication
Study
EGAS00001004466
-
Glioma sequencing data
Study
EGAS00001006355
-
Targeted sequencing of diffuse large B-cell lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001005953
-
Targeted-capture sequencing (bam files) of 81 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005443
-
Embryonal Rhabdomyosarcoma sequencing data
Study
EGAS00001005502
-
An epigenetic single-cell atlas of IDH-mutant glioma reveals the role of ATRX in shaping tumor composition
Study
EGAS00001004523
-
Changes in alternative splicing and associated neo-antigens due to therapy
Study
EGAS00001004524
-
CM214 - Biomarker Analysis From the Phase 3 CheckMate 214 Trial of Nivolumab Plus Ipilimumab (N+I) or Sunitinib (S) in Advanced Renal Cell Carcinoma (aRCC)
Study
EGAS00001005501
-
Conserved interferon-gamma signaling and decreased immune exclusion programs in responses to immune checkpoint blockade therapy
Study
EGAS00001004545
-
Clear cell sarcoma sequencing data
Study
EGAS00001006072
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM67 WES
Study
EGAS00001004555
-
Novel mutations in TOP2A in gliomas
Study
EGAS00001004556
-
Cancer and germline exomes, and cancer RNA-seq consisiting of FASTQ paired-end reads from melanoma, lung and colon cancer samples
Study
EGAS00001005513
-
Microbiota 16S sequencing study in NSCLC patients eligible for surgery without neoadjuvant treatment
Study
EGAS00001004728
-
FACS sorting of ploidy populations in an undifferentiated soft tissue sarcoma for RRBS
Study
EGAS00001006143
-
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocarcinogenesis
Study
EGAS00001004629
-
USARC 10X Genomics Single Cell DNA Sequencing Data
Study
EGAS00001006144
-
Tumour gene expression signature in primary melanoma predicts long-term outcomes: A prospective multicentre study
Study
EGAS00001004664
-
Genomic landscape of malignant peripheral nerve sheath tumor (MPNST)
Study
EGAS00001006069
-
Molecular and functional profiling of plasmablastic lymphoma
Study
EGAS00001004659
-
Genomic and transcriptomic analysis of baseline PDAC patients' tumors from the OXIRI phase 1b clinical trial
Study
EGAS00001006073
-
Osteosarcoma sequencing data
Study
EGAS00001005600
-
Regulatory T cell transcriptomic reprogramming characterizes adverse events by checkpoint inhibitors in solid tumors
Study
EGAS00001004694
-
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
Study
EGAS00001005617
-
Salivary Gland Cancer TSO500 dataset
Study
EGAS00001006232